A research driven and patient-centric clinical stage, private biotechnology company pioneering small molecule inhibition of the twin proteins, p300/CBP
Location: United Kingdom, England, Cambridge
Total raised: $51M
Investors 5
| Date | Name | Website |
| - | Takeda Ven... | takeda.com |
| - | BrightEdge | brightedge... |
| 14.09.2021 | Future Pla... | futureplan... |
| - | Nesta Impa... | nestainves... |
| - | BrightEdge | acsbrighte... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 24.07.2023 | - | $25M | Pfizer Ven... |
| 16.05.2018 | - | $26M | - |
Mentions in press and media 9
| Date | Title | Description | Source |
| 03.11.2023 | CellCentric to present haem clinical data at ASH | Cambridge, UK, November 4th, 2022 – CellCentric, a privately owned, clinical stage biotechnology com... | acsbrighte... |
| 24.07.2023 | CellCentric Receives $25M Strategic Investment from Pfizer | CellCentric, a Cambridge, UK- and and Manchester, UK-based biotechnology company, received a $25M st... | finsmes.co... |
| 16.05.2018 | CellCentric raises $26 million to take first-in-class p300/C... | CellCentric raises $26 million to take first-in-class p300/CBP inhibitor into the clinic 16-05-2018... | cambridgen... |
| 16.05.2018 | CellCentric raises $26 million to take first-in-class p300/C... | CellCentric, based at Chesterford Research Park, has raised $26 million in private financing to fund... | cambridgen... |
| 28.01.2010 | Babraham research provides insight into the reprogramming of... | Babraham research provides insight into the reprogramming of cell fate 28-01-2010 A discovery by B... | cambridgen... |
| 04.10.2007 | Cambridge Corporate Gateway partners strike deal | Cambridge Corporate Gateway partners strike deal 04-10-2007 Cambridge Corporate Gateway's winning ... | cambridgen... |
| 05.06.2007 | CellCentric Limited hits key milestone | CellCentric Limited hits key milestone 05-06-2007 CellCentric Limited, the epigenetics company, hi... | cambridgen... |
| - | CellCentric to present haem clinical data at ASH | Cambridge, UK, November 4th, 2022 – CellCentric, a privately owned, clinical stage biotechnology com... | acsbrighte... |
| - | CellCentric | “CellCentric – The p300/CBP inhibitor company” | fastfounde... |